AYTU
NASDAQ · Pharmaceuticals
Aytu Biopharma Inc
$2.27
+0.02 (+0.89%)
Open$2.31
Previous Close$2.25
Day High$2.31
Day Low$2.23
52W High$3.07
52W Low$1.65
Volume—
Avg Volume31.7K
Market Cap24.79M
P/E Ratio—
EPS$-4.41
SectorPharmaceuticals
Analyst Ratings
Strong Buy
9 analysts
Price Target
+303.1% upside
Current
$2.27
$2.27
Target
$9.15
$9.15
$5.34
$9.15 avg
$10.98
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 113.46M | 128.62M | 4.25M |
| Net Income | -23,179,434 | -23,649,802 | 1.24M |
| Profit Margin | -20.4% | -19.4% | 29.2% |
| EBITDA | -7,082,843 | -7,628,047 | 1.93M |
| Free Cash Flow | — | — | 869.5K |
| Rev Growth | -11.8% | -11.8% | +20.1% |
| Debt/Equity | 1.15 | 1.15 | 0.09 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,107.08 | +0.45% | 40.9 | 1.03T |
| JNJ | Johnson & Johnson | $239.08 | +3.37% | 26.1 | 549.78B |
| MRK | Merck & Co. Inc. | $119.60 | +3.57% | 31.5 | 281.24B |
| PFE | Pfizer Inc. | $24.72 | -1.44% | 19.2 | 143.68B |
| BMY | Bristol-Myers Squibb Co | $55.53 | +1.52% | 18.5 | 110.27B |
| ZTS | Zoetis Inc | $76.84 | +1.25% | 12.5 | 33.00B |